Selective angiotensin II AT2 receptor agonists:: Arylbenzylimidazole structure-activity relationships

被引:41
作者
Wu, Xiongyu
Wan, Yiqian
Mahalingam, A. K.
Murugaiah, A. M. S.
Plouffe, Bianca
Botros, Milad
Karlen, Anders
Hallberg, Mathias
Gallo-Payet, Nicole
Alterman, Mathias [1 ]
机构
[1] Univ Sherbrooke, Fac Med, Dept Physiol & Biophys, Sherbrooke, PQ J1H 5N4, Canada
[2] Univ Sherbrooke, Fac Med, Serv Endocrinol, Sherbrooke, PQ J1H 5N4, Canada
[3] Uppsala Univ, BMC, Dept Med Chem, SE-75123 Uppsala, Sweden
[4] Uppsala Univ, BMC, Dept Biol Res Drug Dependence, SE-75123 Uppsala, Sweden
关键词
D O I
10.1021/jm0606185
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Structural alterations in the 2- and 5-positions of the first drug-like selective angiotensin II AT(2) receptor agonist (1) have been performed. The imidazole ring system was proven to be a strong determinant for the AT(2) selectivity, and with few exceptions all variations gave good AT(2) receptor affinities and with retained high AT(2)/AT(1) selectivities. On the contrary to the findings with AT(1) receptor agonists, the impact of structural modifications in the 5-position of the AT(2) selective compounds were less pronounced regarding activation of the AT(2) receptor. The butyloxyphenyl (56) and the propylthienyl (50) derivatives were found to exert a high agonistic effect as deduced from their capacity to induce neurite elongation in neuronal cells, as does angiotensin II.
引用
收藏
页码:7160 / 7168
页数:9
相关论文
共 33 条
[1]   Pharmacophore, drug metabolism, and pharmacokinetics models on non-peptide AT1, AT2, and AT1/AT2 angiotensin II receptor antagonists [J].
Berellini, G ;
Cruciani, G ;
Mannhold, R .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (13) :4389-4399
[2]   THE ANGIOTENSIN AT2-RECEPTOR MODULATES T-TYPE CALCIUM CURRENT IN NONDIFFERENTIATED NG108-15 CELLS [J].
BUISSON, B ;
BOTTARI, SP ;
DEGASPARO, M ;
GALLOPAYET, N ;
PAYET, MD .
FEBS LETTERS, 1992, 309 (02) :161-164
[3]   NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONISTS - THE DISCOVERY OF A SERIES OF N-(BIPHENYLYLMETHYL)IMIDAZOLES AS POTENT, ORALLY ACTIVE ANTIHYPERTENSIVES [J].
CARINI, DJ ;
DUNCIA, JV ;
ALDRICH, PE ;
CHIU, AT ;
JOHNSON, AL ;
PIERCE, ME ;
PRICE, WA ;
SANTELLA, JB ;
WELLS, GJ ;
WEXLER, RR ;
WONG, PC ;
YOO, SE ;
TIMMERMANS, PBMWM .
JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (08) :2525-2547
[4]   A HIGHLY POTENT, ORALLY-ACTIVE IMIDAZO[4,5-B]PYRIDINE BIPHENYLACYLSULFONAMIDE (MK-996-L-159,282) - A NEW ANGIOTENSIN-II RECEPTOR ANTAGONIST [J].
CHAKRAVARTY, PK ;
NAYLOR, EM ;
CHEN, A ;
CHANG, RSL ;
CHEN, TB ;
FAUST, KA ;
LOTTI, VJ ;
KIVLIGHN, SD ;
GABLE, RA ;
ZINGARO, GJ ;
SCHORN, TW ;
SCHAFFER, LW ;
BROTEN, TP ;
SIEGL, PKS ;
PATCHETT, AA ;
GREENLEE, WJ .
JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (24) :4068-4072
[5]  
de Gasparo M, 2000, PHARMACOL REV, V52, P415
[6]  
DUDLEY DT, 1990, MOL PHARMACOL, V38, P370
[7]   The angiotensin type 2 receptor of angiotensin II and neuronal differentiation: from observations to mechanisms [J].
Gendron, L ;
Payet, MD ;
Gallo-Payet, N .
JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2003, 31 (03) :359-372
[8]   Signals from the AT2 (angiotensin type 2) receptor of angiotensin II inhibit p21ras and activate MAPK (mitogen-activated protein kinase) to induce morphological neuronal differentiation in NG108-15 cells [J].
Gendron, L ;
Laflamme, L ;
Rivard, N ;
Asselin, C ;
Payet, MD ;
Gallo-Payet, N .
MOLECULAR ENDOCRINOLOGY, 1999, 13 (09) :1615-1626
[9]   Nitric oxide and cyclic GMP are involved in angiotensin II AT2 receptor effects on neurite outgrowth in NG108-15 cells [J].
Gendron, L ;
Côté, F ;
Payet, MD ;
Gallo-Payet, N .
NEUROENDOCRINOLOGY, 2002, 75 (01) :70-81
[10]   EXPRESSION OF AT2-RECEPTORS IN THE DEVELOPING RAT FETUS [J].
GRADY, EF ;
SECHI, LA ;
GRIFFIN, CA ;
SCHAMBELAN, M ;
KALINYAK, JE .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (03) :921-933